Social media

Recognising ICON’s Environmental, Social & Governance (ESG) commitment through our ICON Cares programme, we are honoured to be named one of the world’s best by TIME/ Statista. This list ranks the world’s 500 most susta...

For the third and final blog in our series, we discuss ISO 10993-1 in the context of risk estimation. This blog looks at the upcoming revision of ISO 10993-1, which has sparked debate but now is in its final draft stag...

For the third and final article in our series, ICON’s regulatory expert Jeremy Tinkler discusses ISO 10993-1 in the context of risk estimation. This article looks at the upcoming revision of ISO 10993-1, which has spar...

From wearables to ePROs, trials are data-rich and decentralised. CRAs must evolve. ICON’s Helen Yeardley explores this evolution in Applied Clinical Trials. https://ow.ly/TNaS50XB6Sc

From wearables to ePROs, trials are data-rich and decentralised. CRAs must evolve. ICON’s Helen Yeardley explores this evolution in Applied Clinical Trials. https://ow.ly/jXLS50XB6Sb

From wearables to ePROs, trials are data-rich and decentralised. CRAs must evolve. ICON’s Helen Yeardley explores this evolution in Applied Clinical Trials. https://ow.ly/TNaS50XB6Sc

Long-term follow-up for vaccines may seem to be a distant concern when clinical trials are just beginning, but it can be critical to have a plan for follow-up at the outset. Learn considerations for follow-up design, s...

Collecting data through clinical trial tokenisation enables a longitudinal view of patient health, with insights from before and after a clinical trial. This can help to identify factors that may influence the effectiv...

Only 1 week to go. Don’t miss out on your opportunity to hear from ICON’s clinical trial regulatory experts, Jo Hulbert and Jo Sprague on the changes in ICH GCP E6(R3) and the how to assess the impact, risk and requireme...

Only 1 week to go. Don’t miss out on your opportunity to hear from ICON’s clinical trial regulatory experts, Joanne Hulbert, MBA & Joanna Sprague on the changes in ICH GCP E6(R3) and the how to assess the impact, risk ...

Tired of stitching together fragmented market data? Metys®, from Symphony Health, an ICON plc company, is the only fully integrated platform that consolidates over 150 metrics and dimensions – giving you a complete, rea...

Tired of stitching together fragmented market data? Metys®, from Symphony Health, an ICON plc company, is the only fully integrated platform that consolidates over 150 metrics and dimensions – giving you a complete, rea...